Esmée P Hoefsmit
8PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 21, 2023
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation.Elisa A Rozeman, Judith M Versluis, Karolina Sikorska
|Apr 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence.Esmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman
|Feb 08, 2023
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.Esmée P Hoefsmit, Paula T van Royen, Disha Rao
|Jul 12, 2022
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.Tim B Fessenden, Lauren E Stopfer, Fiona Chatterjee
|Feb 09, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.E A Rozeman, E P Hoefsmit, I L M Reijers
|Dec 02, 2020
Comprehensive analysis of cutaneous and uveal melanoma liver metastases.Esmee P Hoefsmit, Elisa A Rozeman, Trieu My Van
Pageof 2
Frequent Collaborators
4 joint publications
Christian U Blank
4 joint publications
Elisa A Rozeman
2 joint publications
P Dimitriadis
2 joint publications
Irene L M Reijers
2 joint publications
John B A G Haanen
2 joint publications
Daniel S Peeper
2 joint publications
Richard A Scolyer
2 joint publications
Georgina V Long
1 joint publications
R P M Saw
1 joint publications
O E Nieweg
